{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:12:50Z","timestamp":1788307970157,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["1020047"],"award-info":[{"award-number":["1020047"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01 DK 126990"],"award-info":[{"award-number":["K01 DK 126990"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK117635"],"award-info":[{"award-number":["R01 DK117635"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver failure secondary to metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common cause for liver transplantation in many parts of the world. Moreover, the prevalence of MASLD not only increases the demand for liver transplantation, but also limits the supply of suitable donor organs because steatosis predisposes grafts to ischemia\u2013reperfusion injury (IRI). There are currently no pharmacological interventions to limit hepatic IRI because the mechanisms by which steatosis leads to increased injury are unclear. To identify potential novel mediators of IRI, we used liquid chromatography and mass spectrometry to assess temporal changes in the hepatic lipidome in steatotic and non-steatotic livers after warm IRI in mice. Our untargeted analyses revealed distinct differences between the steatotic and non-steatotic response to IRI and highlighted dynamic changes in lipid composition with marked changes in glycerophospholipids. These findings enhance our knowledge of the lipidomic changes that occur following IRI and provide a foundation for future mechanistic studies. A better understanding of the mechanisms underlying such changes will lead to novel therapeutic strategies to combat IRI.<\/jats:p>","DOI":"10.1038\/s41598-024-54122-9","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:02:15Z","timestamp":1707782535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Dynamic changes in the mouse hepatic lipidome following warm ischemia reperfusion injury"],"prefix":"10.1038","volume":"14","author":[{"given":"Kim H. H.","family":"Liss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shria","family":"Bucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lutkewitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Allegood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Ashley","family":"Cowart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian N.","family":"Finck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"key":"54122_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","volume":"148","author":"RJ Wong","year":"2015","unstructured":"Wong, R. J. et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148, 547\u2013555. https:\/\/doi.org\/10.1053\/j.gastro.2014.11.039 (2015).","journal-title":"Gastroenterology"},{"key":"54122_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384. https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatology"},{"key":"54122_CR3","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343\u20131351. https:\/\/doi.org\/10.1172\/JCI23621 (2005).","journal-title":"J. Clin. Invest."},{"key":"54122_CR4","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323 (2023).","journal-title":"Hepatology"},{"key":"54122_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"54122_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cld.2014.05.005","volume":"18","author":"S Feng","year":"2014","unstructured":"Feng, S. & Lai, J. C. Expanded criteria donors. Clin. Liver Dis. 18, 633\u2013649. https:\/\/doi.org\/10.1016\/j.cld.2014.05.005 (2014).","journal-title":"Clin. Liver Dis."},{"key":"54122_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrgastro.2012.225","volume":"10","author":"Y Zhai","year":"2013","unstructured":"Zhai, Y., Petrowsky, H., Hong, J. C., Busuttil, R. W. & Kupiec-Weglinski, J. W. Ischaemia-reperfusion injury in liver transplantation\u2013from bench to bedside. Nat. Rev. Gastroenterol. Hepatol. 10, 79\u201389. https:\/\/doi.org\/10.1038\/nrgastro.2012.225 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"54122_CR8","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.ijsu.2016.05.050","volume":"33","author":"M Cannistra","year":"2016","unstructured":"Cannistra, M. et al. Hepatic ischemia reperfusion injury: A systematic review of literature and the role of current drugs and biomarkers. Int. J. Surg. 33(Suppl 1), S57-70. https:\/\/doi.org\/10.1016\/j.ijsu.2016.05.050 (2016).","journal-title":"Int. J. Surg."},{"key":"54122_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1053\/jlts.2003.50099","volume":"9","author":"D Verran","year":"2003","unstructured":"Verran, D. et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl. 9, 500\u2013505. https:\/\/doi.org\/10.1053\/jlts.2003.50099 (2003).","journal-title":"Liver Transpl."},{"key":"54122_CR10","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/00007890-199611150-00011","volume":"62","author":"WA Marsman","year":"1996","unstructured":"Marsman, W. A. et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 62, 1246\u20131251 (1996).","journal-title":"Transplantation"},{"key":"54122_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nm.4451","volume":"24","author":"XJ Zhang","year":"2018","unstructured":"Zhang, X. J. et al. An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury. Nat. Med. 24, 73\u201383. https:\/\/doi.org\/10.1038\/nm.4451 (2018).","journal-title":"Nat. Med."},{"key":"54122_CR12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1053\/j.gastro.2012.12.028","volume":"144","author":"Z Cao","year":"2013","unstructured":"Cao, Z. et al. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice. Gastroenterology 144, 808\u2013817. https:\/\/doi.org\/10.1053\/j.gastro.2012.12.028 (2013).","journal-title":"Gastroenterology"},{"key":"54122_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/hep.21285","volume":"44","author":"L Llacuna","year":"2006","unstructured":"Llacuna, L., Mari, M., Garcia-Ruiz, C., Fernandez-Checa, J. C. & Morales, A. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology 44, 561\u2013572. https:\/\/doi.org\/10.1002\/hep.21285 (2006).","journal-title":"Hepatology"},{"key":"54122_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/lt.25886","volume":"27","author":"KHH Liss","year":"2021","unstructured":"Liss, K. H. H. et al. Monoacylglycerol acyltransferase 1 knockdown exacerbates hepatic ischemia\/reperfusion injury in mice with hepatic steatosis. Liver Transpl. 27, 116\u2013133. https:\/\/doi.org\/10.1002\/lt.25886 (2021).","journal-title":"Liver Transpl."},{"key":"54122_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11010-014-2282-1","volume":"400","author":"JC Martens","year":"2015","unstructured":"Martens, J. C. et al. Lipidomic analysis of molecular cardiolipin species in livers exposed to ischemia\/reperfusion. Mol. Cell Biochem. 400, 253\u2013263. https:\/\/doi.org\/10.1007\/s11010-014-2282-1 (2015).","journal-title":"Mol. Cell Biochem."},{"key":"54122_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633657","volume":"9","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., He, X., Simonaro, C. M., Yi, B. & Schuchman, E. H. Acid ceramidase protects against hepatic ischemia\/reperfusion injury by modulating sphingolipid metabolism and reducing inflammation and oxidative stress. Front. Cell Dev. Biol. 9, 633657. https:\/\/doi.org\/10.3389\/fcell.2021.633657 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"54122_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/10715762.2017.1298103","volume":"51","author":"H Tuzcu","year":"2017","unstructured":"Tuzcu, H. et al. Neutral sphingomyelinase inhibition alleviates apoptosis, but not ER stress, in liver ischemia-reperfusion injury. Free Radic. Res. 51, 253\u2013268. https:\/\/doi.org\/10.1080\/10715762.2017.1298103 (2017).","journal-title":"Free Radic. Res."},{"key":"54122_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrendo.2016.98","volume":"12","author":"X Han","year":"2016","unstructured":"Han, X. Lipidomics for studying metabolism. Nat. Rev. Endocrinol. 12, 668\u2013679. https:\/\/doi.org\/10.1038\/nrendo.2016.98 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"54122_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1146\/annurev-biochem-061009-102430","volume":"81","author":"TC Walther","year":"2012","unstructured":"Walther, T. C. & Farese, R. V. Jr. Lipid droplets and cellular lipid metabolism. Annu. Rev. Biochem. 81, 687\u2013714. https:\/\/doi.org\/10.1146\/annurev-biochem-061009-102430 (2012).","journal-title":"Annu. Rev. Biochem."},{"key":"54122_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","volume":"34","author":"S Klein","year":"2022","unstructured":"Klein, S., Gastaldelli, A., Yki-Jarvinen, H. & Scherer, P. E. Why does obesity cause diabetes?. Cell Metab. 34, 11\u201320. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.012 (2022).","journal-title":"Cell Metab."},{"key":"54122_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103216","volume":"64","author":"S Lefevre-Arbogast","year":"2021","unstructured":"Lefevre-Arbogast, S. et al. Early signature in the blood lipidome associated with subsequent cognitive decline in the elderly: A case-control analysis nested within the Three-City cohort study. EBioMedicine 64, 103216. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103216 (2021).","journal-title":"EBioMedicine"},{"key":"54122_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: The role of lipid metabolism in cancer. Cell Metab. 31, 62\u201376. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.010 (2020).","journal-title":"Cell Metab."},{"key":"54122_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41577-021-00529-8","volume":"21","author":"K Voss","year":"2021","unstructured":"Voss, K. et al. A guide to interrogating immunometabolism. Nat. Rev. Immunol. 21, 637\u2013652. https:\/\/doi.org\/10.1038\/s41577-021-00529-8 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"54122_CR24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/lt.25189","volume":"24","author":"KHH Liss","year":"2018","unstructured":"Liss, K. H. H. et al. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia\/reperfusion injury. Liver Transpl. 24, 908\u2013921. https:\/\/doi.org\/10.1002\/lt.25189 (2018).","journal-title":"Liver Transpl."},{"key":"54122_CR25","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt, E. M. et al. Nonalcoholic fatty liver disease. Nat. Rev. Dis. Prim. 1, 15080. https:\/\/doi.org\/10.1038\/nrdp.2015.80 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"54122_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11894-009-0083-6","volume":"12","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri, B. A. Nontriglyceride hepatic lipotoxicity: The new paradigm for the pathogenesis of NASH. Curr. Gastroenterol. Rep. 12, 49\u201356. https:\/\/doi.org\/10.1007\/s11894-009-0083-6 (2010).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"54122_CR27","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.dld.2011.07.009","volume":"43","author":"HA Marsman","year":"2011","unstructured":"Marsman, H. A. et al. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats. Dig. Liver Dis. 43, 984\u2013990. https:\/\/doi.org\/10.1016\/j.dld.2011.07.009 (2011).","journal-title":"Dig. Liver Dis."},{"key":"54122_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.nutres.2010.10.010","volume":"30","author":"S Zeghichi-Hamri","year":"2010","unstructured":"Zeghichi-Hamri, S. et al. Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats. Nutr. Res. 30, 849\u2013857. https:\/\/doi.org\/10.1016\/j.nutres.2010.10.010 (2010).","journal-title":"Nutr. Res."},{"key":"54122_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.fct.2018.03.014","volume":"115","author":"AJ Lutkewitte","year":"2018","unstructured":"Lutkewitte, A. J. et al. Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration. Food Chem. Toxicol. 115, 273\u2013283. https:\/\/doi.org\/10.1016\/j.fct.2018.03.014 (2018).","journal-title":"Food Chem. Toxicol."},{"key":"54122_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajpath.2013.04.034","volume":"184","author":"J Huang","year":"2014","unstructured":"Huang, J. & Rudnick, D. A. Elucidating the metabolic regulation of liver regeneration. Am. J. Pathol. 184, 309\u2013321. https:\/\/doi.org\/10.1016\/j.ajpath.2013.04.034 (2014).","journal-title":"Am. J. Pathol."},{"key":"54122_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fendo.2018.00221","volume":"9","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. The mitotic and metabolic effects of phosphatidic acid in the primary muscle cells of turbot (Scophthalmus maximus). Front. Endocrinol. 9, 221. https:\/\/doi.org\/10.3389\/fendo.2018.00221 (2018).","journal-title":"Front. Endocrinol."},{"key":"54122_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1743-7075-11-29","volume":"11","author":"JM Joy","year":"2014","unstructured":"Joy, J. M. et al. Phosphatidic acid enhances mTOR signaling and resistance exercise induced hypertrophy. Nutr. Metab. 11, 29. https:\/\/doi.org\/10.1186\/1743-7075-11-29 (2014).","journal-title":"Nutr. Metab."},{"key":"54122_CR33","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1126\/science.1066015","volume":"294","author":"Y Fang","year":"2001","unstructured":"Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. & Chen, J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294, 1942\u20131945. https:\/\/doi.org\/10.1126\/science.1066015 (2001).","journal-title":"Science"},{"key":"54122_CR34","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1558\u20131572","author":"JN van der Veen","year":"1859","unstructured":"van der Veen, J. N. et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim. Biophys. Acta Biomembr. 1558\u20131572, 2017. https:\/\/doi.org\/10.1016\/j.bbamem.2017.04.006 (1859).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"54122_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","volume":"3","author":"Z Li","year":"2006","unstructured":"Li, Z. et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 3, 321\u2013331. https:\/\/doi.org\/10.1016\/j.cmet.2006.03.007 (2006).","journal-title":"Cell Metab."},{"key":"54122_CR36","doi-asserted-by":"publisher","first-page":"37798","DOI":"10.1074\/jbc.M508575200","volume":"280","author":"Z Li","year":"2005","unstructured":"Li, Z., Agellon, L. B. & Vance, D. E. Phosphatidylcholine homeostasis and liver failure. J. Biol. Chem. 280, 37798\u201337802. https:\/\/doi.org\/10.1074\/jbc.M508575200 (2005).","journal-title":"J. Biol. Chem."},{"key":"54122_CR37","doi-asserted-by":"publisher","first-page":"21721","DOI":"10.1038\/srep21721","volume":"6","author":"A Nakatsuka","year":"2016","unstructured":"Nakatsuka, A. et al. Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis. Sci. Rep. 6, 21721. https:\/\/doi.org\/10.1038\/srep21721 (2016).","journal-title":"Sci. Rep."},{"key":"54122_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363. https:\/\/doi.org\/10.1038\/nature09922 (2011).","journal-title":"Nature"},{"key":"54122_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2021.101037","volume":"27","author":"JF Montero-Bullon","year":"2021","unstructured":"Montero-Bullon, J. F. et al. Cardiac phospholipidome is altered during ischemia and reperfusion in an ex vivo rat model. Biochem. Biophys. Rep. 27, 101037. https:\/\/doi.org\/10.1016\/j.bbrep.2021.101037 (2021).","journal-title":"Biochem. Biophys. Rep."},{"key":"54122_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","volume":"35","author":"L Whiley","year":"2014","unstructured":"Whiley, L. et al. Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease. Neurobiol. Aging 35, 271\u2013278. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.08.001 (2014).","journal-title":"Neurobiol. Aging"},{"key":"54122_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.brainres.2016.04.035","volume":"1642","author":"M Ko","year":"2016","unstructured":"Ko, M. et al. Phosphatidylcholine protects neurons from toxic effects of amyloid beta-protein in culture. Brain Res. 1642, 376\u2013383. https:\/\/doi.org\/10.1016\/j.brainres.2016.04.035 (2016).","journal-title":"Brain Res."},{"key":"54122_CR42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/hep.24782","volume":"55","author":"J Ling","year":"2012","unstructured":"Ling, J., Chaba, T., Zhu, L. F., Jacobs, R. L. & Vance, D. E. Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice. Hepatology 55, 1094\u20131102. https:\/\/doi.org\/10.1002\/hep.24782 (2012).","journal-title":"Hepatology"},{"key":"54122_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12944-017-0540-4","volume":"16","author":"YN Ming","year":"2017","unstructured":"Ming, Y. N. et al. Liquid chromatography mass spectrometry-based profiling of phosphatidylcholine and phosphatidylethanolamine in the plasma and liver of acetaminophen-induced liver injured mice. Lipids Health Dis. 16, 153. https:\/\/doi.org\/10.1186\/s12944-017-0540-4 (2017).","journal-title":"Lipids Health Dis."},{"key":"54122_CR44","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1002\/hep.31391","volume":"73","author":"Z Hall","year":"2021","unstructured":"Hall, Z. et al. Lipid remodeling in hepatocyte proliferation and hepatocellular carcinoma. Hepatology 73, 1028\u20131044. https:\/\/doi.org\/10.1002\/hep.31391 (2021).","journal-title":"Hepatology"},{"key":"54122_CR45","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1097\/SHK.0b013e31816f204a","volume":"30","author":"M Ghyczy","year":"2008","unstructured":"Ghyczy, M. et al. Oral phosphatidylcholine pretreatment decreases ischemia-reperfusion-induced methane generation and the inflammatory response in the small intestine. Shock 30, 596\u2013602. https:\/\/doi.org\/10.1097\/SHK.0b013e31816f204a (2008).","journal-title":"Shock"},{"key":"54122_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/jbt.20037","volume":"18","author":"DM Aabdallah","year":"2004","unstructured":"Aabdallah, D. M. & Eid, N. I. Possible neuroprotective effects of lecithin and alpha-tocopherol alone or in combination against ischemia\/reperfusion insult in rat brain. J. Biochem. Mol. Toxicol. 18, 273\u2013278. https:\/\/doi.org\/10.1002\/jbt.20037 (2004).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"54122_CR47","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/lt.25179","volume":"24","author":"C Zazueta","year":"2018","unstructured":"Zazueta, C. et al. Cytidine-5\u2019-diphosphocholine protects the liver from ischemia\/reperfusion injury preserving mitochondrial function and reducing oxidative stress. Liver Transpl. 24, 1070\u20131083. https:\/\/doi.org\/10.1002\/lt.25179 (2018).","journal-title":"Liver Transpl."},{"key":"54122_CR48","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1161\/01.CIR.0000093187.42015.6C","volume":"108","author":"TL Yue","year":"2003","unstructured":"Yue, T. L. et al. Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia\/reperfusion injury. Circulation 108, 2393\u20132399. https:\/\/doi.org\/10.1161\/01.CIR.0000093187.42015.6C (2003).","journal-title":"Circulation"},{"key":"54122_CR49","doi-asserted-by":"publisher","first-page":"5849794","DOI":"10.1155\/2020\/5849794","volume":"2020","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. Mild hypothermia attenuates hepatic ischemia-reperfusion injury through regulating the JAK2\/STAT3-CPT1a-dependent fatty acid beta-oxidation. Oxid. Med. Cell Longev. 2020, 5849794. https:\/\/doi.org\/10.1155\/2020\/5849794 (2020).","journal-title":"Oxid. Med. Cell Longev."},{"key":"54122_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4318\/tjg.2013.0645","volume":"24","author":"AH Cekin","year":"2013","unstructured":"Cekin, A. H. et al. The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats. Turk. J. Gastroenterol. 24, 51\u201356 (2013).","journal-title":"Turk. J. Gastroenterol."},{"key":"54122_CR51","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1042\/BCJ20160164","volume":"473","author":"E Liepinsh","year":"2016","unstructured":"Liepinsh, E. et al. Long-chain acylcarnitines determine ischaemia\/reperfusion-induced damage in heart mitochondria. Biochem. J. 473, 1191\u20131202. https:\/\/doi.org\/10.1042\/BCJ20160164 (2016).","journal-title":"Biochem. J."},{"key":"54122_CR52","doi-asserted-by":"publisher","first-page":"H1341","DOI":"10.1152\/ajpheart.00028.2018","volume":"315","author":"G Paradies","year":"2018","unstructured":"Paradies, G., Paradies, V., Ruggiero, F. M. & Petrosillo, G. Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: Implications for pharmacological cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 315, H1341\u2013H1352. https:\/\/doi.org\/10.1152\/ajpheart.00028.2018 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"54122_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1006\/jsre.2001.6324","volume":"102","author":"JA Crestanello","year":"2002","unstructured":"Crestanello, J. A. et al. Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion. J. Surg. Res. 102, 221\u2013228. https:\/\/doi.org\/10.1006\/jsre.2001.6324 (2002).","journal-title":"J. Surg. Res."},{"key":"54122_CR54","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.2000.278.4.H1084","volume":"278","author":"N Maulik","year":"2000","unstructured":"Maulik, N. et al. Dietary coenzyme Q(10) supplement renders swine hearts resistant to ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 278, H1084-1090. https:\/\/doi.org\/10.1152\/ajpheart.2000.278.4.H1084 (2000).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"54122_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tice.2019.07.007","volume":"60","author":"AR Mahmoud","year":"2019","unstructured":"Mahmoud, A. R., Ali, F. E. M., Abd-Elhamid, T. H. & Hassanein, E. H. M. Coenzyme Q10 protects hepatocytes from ischemia reperfusion-induced apoptosis and oxidative stress via regulation of Bax\/Bcl-2\/PUMA and Nrf-2\/FOXO-3\/Sirt-1 signaling pathways. Tissue Cell 60, 1\u201313. https:\/\/doi.org\/10.1016\/j.tice.2019.07.007 (2019).","journal-title":"Tissue Cell"},{"key":"54122_CR56","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/hep.510250514","volume":"25","author":"CA Bradham","year":"1997","unstructured":"Bradham, C. A. et al. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases. Hepatology 25, 1128\u20131135. https:\/\/doi.org\/10.1002\/hep.510250514 (1997).","journal-title":"Hepatology"},{"key":"54122_CR57","first-page":"1257","volume":"151","author":"AE Bielawska","year":"1997","unstructured":"Bielawska, A. E. et al. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am. J. Pathol. 151, 1257\u20131263 (1997).","journal-title":"Am. J. Pathol."},{"key":"54122_CR58","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","volume":"141","author":"Y Hadas","year":"2020","unstructured":"Hadas, Y. et al. Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction. Circulation 141, 916\u2013930. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041882 (2020).","journal-title":"Circulation"},{"key":"54122_CR59","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/164_2021_573","volume":"274","author":"G Mocciaro","year":"2022","unstructured":"Mocciaro, G. & Gastaldelli, A. Obesity-related insulin resistance: The central role of adipose tissue dysfunction. Handb. Exp. Pharmacol. 274, 145\u2013164. https:\/\/doi.org\/10.1007\/164_2021_573 (2022).","journal-title":"Handb. Exp. Pharmacol."},{"key":"54122_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13695","volume":"52","author":"S Guerra","year":"2022","unstructured":"Guerra, S., Mocciaro, G. & Gastaldelli, A. Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis. Eur. J. Clin. Invest. 52, e13695. https:\/\/doi.org\/10.1111\/eci.13695 (2022).","journal-title":"Eur. J. Clin. Invest."},{"key":"54122_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101728","volume":"73","author":"G Mocciaro","year":"2023","unstructured":"Mocciaro, G. et al. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Mol. Metab. 73, 101728. https:\/\/doi.org\/10.1016\/j.molmet.2023.101728 (2023).","journal-title":"Mol. Metab."},{"key":"54122_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2008.09.029","volume":"46","author":"Y Abe","year":"2009","unstructured":"Abe, Y. et al. Mouse model of liver ischemia and reperfusion injury: Method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic. Biol. Med. 46, 1\u20137. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.09.029 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"54122_CR63","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917. https:\/\/doi.org\/10.1139\/o59-099 (1959).","journal-title":"Can. J. Biochem. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54122-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T06:14:56Z","timestamp":1708150496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-54122-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54122"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-54122-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.07.10.499482","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.N.F. is a member of the scientific advisory board for and has stock in Cirius Therapeutics. This relationship is not relevant to the focus of the paper.  All other authors do not have any competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3584"}}